JFCBS FRAGO 056 Amendment 2 - Key Points
Maintaining JFCBS Operational Capability in a COVID-19 Safe Environment FRAGO 056, Amendment 2 – Key Points
To ensure the highest possible validity, applicability, and efficacy in tackling COVID-19, it is necessary to regularly amend FRAGO 056.
The following are key points extracted from Amendment 2. FRAGO 056 came into effect 1600 Mon 18 Jan and, together with these amendments, remains valid until further notice:
- The negative travel advice remains in force in The Netherlands until (at least) 15 April 2021;
- The Easter break JFCBS reduced the manning period will commence close of business Friday 26 Mar. Normal manning will resume Monday 12 Apr;
- For the Easter period, the requirement is that everybody absent from The Netherlands for more than 72 hours must be tested. Increased testing requirements will be introduced for those travelling between 26 Mar – 12 Apr 21 or any combination of dates that includes leave during this period;
- For the Easter period, all daily and weekly cross-border workers absent from the Netherlands for more than 72 hours must have a negative PCR/antigen test which is not older than 48 hours, to enter JFCBS HQ buildings;
- All staff, irrespective of country of residence, are to consider whether their actions over the Easter reduced manning period require them to undertake a voluntary test before returning to work post-Easter leave. All staff have an obligation to consider their co-workers' safety and undertake a test within 48 hours of returning to work if their daily routines significantly differed from the norm. For the return to work post-Easter leave and as a trial, any licensed self-tests approved in any NATO country are acceptable;
- A separate FRAGO on the expansion of testing is to follow;
- Option to shorten quarantine in accordance with extant Dutch regulation: individuals tested on the 5th day of quarantine can shorten the quarantine period if the PCR test result is negative;
- Vaccinated JFCBS personnel still need to apply to all COVID-19 mitigation measures.